Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial
Articolo
Data di Pubblicazione:
2022
Citazione:
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial / Metra, Marco; Jankowska, Ewa A; Pagnesi, Matteo; Anker, Stefan D; Butler, Javed; Dorigotti, Fabio; Fabien, Vincent; Filippatos, Gerasimos; Kirwan, Bridget-Anne; Macdougall, Iain C; Rosano, Giuseppe; Ruschitzka, Frank; Tomasoni, Daniela; Van Der Meer, Peter; Ponikowski, Piotr. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - (2022). [10.1002/ejhf.2630]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Metra, Marco; Jankowska, Ewa A; Pagnesi, Matteo; Anker, Stefan D; Butler, Javed; Dorigotti, Fabio; Fabien, Vincent; Filippatos, Gerasimos; Kirwan, Bridget-Anne; Macdougall, Iain C; Rosano, Giuseppe; Ruschitzka, Frank; Tomasoni, Daniela; Van Der Meer, Peter; Ponikowski, Piotr
Link alla scheda completa:
Pubblicato in: